TAMPA, Fla.--(BUSINESS WIRE)--AnazaoHealth® Corporation announced today that it has applied for and, on June 12, 2007, a patent will be issued for a Stabilized and Lyophilized Radiopharmaceutical Agents. The invention being patented relates to the method of preparation and stabilization of a diagnostic or therapeutic radiopharmaceutical useful, in mammalian imaging and cancer detection, and resulting composition. In particular, the present invention is a novel method of preparation of radioactive diagnostic radiopharmaceutical in a stable, shippable, lyophilized form by an apparatus designed to rapidly flash freeze and dehydrate a radiopharmaceutical composition to minimize radiolysis. “AnazaoHealth has been meeting customer’s needs by stabilizing radiopharmaceutical preparations such as MIBG I-123 since August, 2003. We are dedicated to creating and providing the most powerful innovations in healing for our patients. With U.S. Patent No. 7229603, we are better able to serve our clients and their patients by providing faster, more efficient service,” said Jacob Beckel, Chairman and Chief Executive Officer of AnazaoHealth.
